47 algorithm-development-"Multiple"-"Simons-Foundation"-"Prof"-"UCL" Fellowship positions at Nature Careers in United States
Sort by
Refine Your Search
-
., somatic) somatic mutations in the human brain. The lab is interested in studying somatic variation as it pertains to typical brain development as well as in neurological diseases like epilepsy. To that end
-
. Dr. Wang's laboratory conducts cutting-edge research to understand the evolution of cancer transcriptomes through DNA-RNA dynamics, aiming to uncover mechanisms of cancer initiation, progression, and
-
meetings. • Develop independent research questions that align with the division's mission. • Mentor students and junior research staff, as appropriate. Required Qualifications: • Ph.D. or M.D./Ph.D. in
-
career development of young investigators in the field of basic and translational hematology. Postdoc candidates will also have the opportunity to learn basic and clinical hematology, innate immunity
-
experiments, analyze and interpret the data; Prepare scientific presentations and publications Supervises the experiments and data analysis of technicians or students as needed Qualifications: Ph.Ds or M.D
-
interested in the dynamics of beta-cell heterogeneity, islet organization and cell-cell interaction in fetal and neonatal development. The Dhawan lab utilizes genetic mouse models, molecular biology, imaging
-
care to patients of all ages; we conduct research that advances treatment; we educate tomorrow's physician/researchers; we reach out to underserved members of our community; and we work with amazing
-
Imperial College Research Fellowship £48,056 - £56,345 per annum About the role: Imperial College London is promoting our exciting opportunity for outstanding early career researchers to develop
-
and cancer. Ultimately, we aim to mitigate the pathogenesis and develop treatments for chronic metabolic diseases. We have established unique, comprehensive mouse models for: 1) real-time labeling and
-
regulation and other aspects of cellular signal transduction. We use our structural and mechanistic insights to drive development of novel anti-cancer drugs. Systems of current interest in the lab include RAF